2005
DOI: 10.1016/s1359-6446(05)03698-6
|View full text |Cite
|
Sign up to set email alerts
|

Essential properties of drug-targeting delivery systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
66
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
3
3
3

Relationship

1
8

Authors

Journals

citations
Cited by 118 publications
(67 citation statements)
references
References 36 publications
0
66
0
Order By: Relevance
“…Amphiphiles with hydrophilic headgroups could be chemically linked to molecules such as folate, transferrin or the epidermal growth factor that potentiate specific delivery to cancer cells, markedly increasing the therapeutic benefits achieved with lipoplexes, with little secondary effects [114][115][116][117][118].…”
Section: Recent Progress In Gene Delivery With Cationic Lipidsmentioning
confidence: 99%
“…Amphiphiles with hydrophilic headgroups could be chemically linked to molecules such as folate, transferrin or the epidermal growth factor that potentiate specific delivery to cancer cells, markedly increasing the therapeutic benefits achieved with lipoplexes, with little secondary effects [114][115][116][117][118].…”
Section: Recent Progress In Gene Delivery With Cationic Lipidsmentioning
confidence: 99%
“…Solubility, for example, is one of the leading factors hindering oral absorption and reducing bioavailability, and a great deal of effort is being put into determining methods to increase solubility of therapeutics in aqueous environments [63]. For example, chemical modifications to the drug molecules to generate prodrugs with increased aqueous solubility are being explored, as are methods of solid dispersion.…”
Section: Bioavailabilitymentioning
confidence: 99%
“…The idea of developing a drug that selectively destroy disease cells without damaging healthy cells was proposed by Paul Ehrlich, almost a century ago; he called his hypothetical drug the "magic bullet" [17][18][19] . Thereafter, over the past several decades, many scientists have focused their attention on the development of ideal drugs that specifically target the site of action.…”
Section: Proteins As Anticancer Drug Targeting Carriersmentioning
confidence: 99%